KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Other Non Operating Income (2016 - 2025)

Globus Medical (GMED) has disclosed Other Non Operating Income for 15 consecutive years, with $109.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income rose 392.33% year-over-year to $109.6 million, compared with a TTM value of $117.7 million through Dec 2025, up 532.67%, and an annual FY2025 reading of $117.7 million, up 371.93% over the prior year.
  • Other Non Operating Income was $109.6 million for Q4 2025 at Globus Medical, up from $3.8 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $109.6 million in Q4 2025 and bottomed at -$37.5 million in Q4 2024.
  • Average Other Non Operating Income over 5 years is $4.8 million, with a median of $210500.0 recorded in 2021.
  • The sharpest move saw Other Non Operating Income tumbled 2149.41% in 2021, then soared 1458.27% in 2023.
  • Year by year, Other Non Operating Income stood at -$454000.0 in 2021, then tumbled by 1662.11% to -$8.0 million in 2022, then surged by 69.3% to -$2.5 million in 2023, then crashed by 1426.47% to -$37.5 million in 2024, then skyrocketed by 392.33% to $109.6 million in 2025.
  • Business Quant data shows Other Non Operating Income for GMED at $109.6 million in Q4 2025, $3.8 million in Q3 2025, and $38000.0 in Q2 2025.